欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  NF-κB  /  Edasalonexent

CAS No.: 1204317-86-1

Edasalonexent Catalog No. CSN21353

Synonyms: CAT-1004

Edasalonexent is an orally bioavailable NF-κB inhibitor.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT02439216Muscular Dystrophy, DuchennePhase 1 Phase 2Active, not recruitingAugust 2019United States, California ... more >> Los Angeles, California, United States, 90095 United States, Florida Gainesville, Florida, United States, 32610 Orlando, Florida, United States, 32827 United States, Oregon Portland, Oregon, United States, 97239 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
    NCT03703882Muscular Dystrophy, DuchennePhase 3RecruitingJune 2020United States, Arkansas ... more >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Vikki A Stefans, MD          Principal Investigator: Vikki A Stefans, MD          United States, Georgia Rare Disease Research, LLC Recruiting Atlanta, Georgia, United States, 30318 Contact: Tu Tran, BS          Principal Investigator: Han Phan, MD          United States, Maryland Kennedy Krieger Institute Recruiting Baltimore, Maryland, United States, 21205 Contact: Genila Bibat, MD          Principal Investigator: Katherine R Wagner, MD, PhD          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Amy Hurst, CCRC          Principal Investigator: Erin Neil, DO          United States, Oregon Shriners Hospitals for Children Recruiting Portland, Oregon, United States, 97239 Contact: Paige Lemhouse, BS          Principal Investigator: Erika Finanger, MD Collapse <<

实验方案

技术信息

CAS号 1204317-86-1 储存条件
分子式 C31H42N2O3 运输 蓝冰
分子量 490.68 别名 CAT-1004

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们